On December 7th 2006, approval was given for the creation of the seventh institute in the biomedical sciences cluster of Singapore’s Agency for Science, Technology and Research (A*STAR). One year later, the Institute of Medical Biology had its formal opening on December 7th 2007. The IMB started began as a coalescence of research programmes from the Centre for Molecular Medicine and the laboratories of the Singapore Stem Cell Consortium, and was rapidly joined by groups from top institutions and biotech around the world. In 2011 we will have over 20 research teams in IMB.
Research activities in IMB today range across stem cells, development and differentiation, skin biology, cancer and genetic diseases. By studying how molecular changes lead to increasing cell specialization and complexity in the context of human tissues and diseases, new knowledge gained will lead us to novel therapeutic strategies for improved quality of life. From Singapore and around the world, our scientists are bringing together their pioneering spirit and creative research talent to form a research institute of international excellence. IMB’s research will help to build the bridges between basic science and clinical medicine that are so necessary to nurture an innovative and productive biomedical industry here in Singapore.